Locally Recurrent Retroperitoneal Soft Tissue Sarcoma

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Locally Recurrent Retroperitoneal Soft Tissue Sarcoma trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 1

NCT06812052

Short Course Radiation Treatment for Patients With Primary or Locally Recurrent Retroperitoneal Sarcoma Prior to Surgery

To determine the safety of moderately hypofractionated radiation in the treatment of primary and locally recurrent RPS, based on the evaluation of acute radiati…

United States6 participantsStarted 2025-05-29

Treatment: Radiation Therapy, Hypofractionationed Radiation Therapy

All recent trials (3 shown)

Not Yet RecruitingPhase 1

NCT07578506

A Study of Ta-NPs Plus Radiotherapy for Locally Recurrent Retroperitoneal Sarcoma

This prospective, single-arm, open-label phase I study evaluates the safety and tolerability of intratumoral injection of tantalum nanoparticles (Ta-NPs) follow…

China9 participantsStarted 2026-05-01

Treatment: Ta-NPs (2% Tumor Volume), Ta-NPs (5% Tumor Volume)

CompletedPhase 1

NCT04619056

First-in-man Clinical Trial of CEB-01 PLGA Membrane in Recurrent or Locally Advanced Retroperitoneal Soft Tissue Sarcoma

This is an open label, first-in-man clinical trial to assess safety and tolerability of CEB-01 PLGA membrane in patients with recurrent or locally advanced retr…

Spain21 participantsStarted 2020-06-03

Treatment: CEB-01 membrane loaded with SN-38